Good news!
"The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million adults in the US alone, has been approved by the Food and Drug Administration (FDA) and will be available within three months. ..."
LENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment of Presbyopia (company press release)
No comments:
Post a Comment